FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034225161> ?p ?o ?g. }

• W2034225161 endingPage "741" @default.
• W2034225161 startingPage "734" @default.
• W2034225161 abstract "Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) are altered in women with clinical preeclampsia. We sought to identify whether similar alterations in urinary levels of these proteins cluster hypertensive disorders in pregnancy, and identify women with severe preeclampsia (sPE).Free urinary levels of sFlt-1, VEGF, and PlGF were measured by immunoassay in 68 women enrolled prospectively in the following groups: nonpregnant reproductive age (NP-CTR n = 14), healthy pregnant control (P-CTR n = 16), pregnant hypertensive and proteinuric women who did not meet criteria for severe preeclampsia (pHTN n = 21), and women with sPE (n = 17).There was no difference in gestational age at the time of enrollment among groups (median [range]: sPE: 31 [24-40], pHTN: 34 [16-40], P-CTR: 28 [7-39] wks). Urinary excretion of VEGF was significantly increased in sPE women compared with NP-CTR (P = .023), but did not differ among pregnant groups. Urinary PlGF levels were significantly increased in pregnant compared with nonpregnant women, but were decreased in all hypertensive women compared with healthy P-CTR (P < .001). Urinary sFlt-1 concentrations were significantly increased in women with sPE relative to all other groups (P < .001). pHTN women had higher sFlt-1 urinary output compared with P-CTR group (P = .001). A cutoff >2.1 in the ratio log [sFlt-1/PlGF] had 88.2% sensitivity and 100% specificity in differentiating women with sPE from normotensive controls. We also described that the log[sFlt-1/PlGF] ratio identified women with sPE better than proteinuria alone (P = .03). Our regression model revealed that uric acid correlated best with log[sFlt-1/PlGF] ratio (r = 0.628; P = .005).sPE is associated with increased urinary output of the antiangiogenic factor sFlt-1 and a decreased output of PlGF at the time of clinical manifestation, providing a rapid noninvasive screening of hypertensive women based on a sFlt/PlGF ratio. This ratio may be used as representation for severity of the disease, and appears to be superior to random urinary protein measurements." @default.
• W2034225161 created "2016-06-24" @default.
• W2034225161 creator A5005680652 @default.
• W2034225161 creator A5020083084 @default.
• W2034225161 creator A5047214799 @default.
• W2034225161 creator A5064904642 @default.
• W2034225161 creator A5066655749 @default.
• W2034225161 creator A5074359125 @default.
• W2034225161 creator A5079468194 @default.
• W2034225161 date "2005-03-01" @default.
• W2034225161 modified "2023-10-16" @default.
• W2034225161 title "Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia" @default.
• W2034225161 cites W1666120340 @default.
• W2034225161 cites W1980421688 @default.
• W2034225161 cites W1991959440 @default.
• W2034225161 cites W1999647741 @default.
• W2034225161 cites W2003774981 @default.
• W2034225161 cites W2014871892 @default.
• W2034225161 cites W2015615198 @default.
• W2034225161 cites W2036397500 @default.
• W2034225161 cites W2051563676 @default.
• W2034225161 cites W2053976090 @default.
• W2034225161 cites W2075856349 @default.
• W2034225161 cites W2078232348 @default.
• W2034225161 cites W2078709831 @default.
• W2034225161 cites W2081734842 @default.
• W2034225161 cites W2082057874 @default.
• W2034225161 cites W2091580324 @default.
• W2034225161 cites W2118661107 @default.
• W2034225161 cites W2123266930 @default.
• W2034225161 cites W2126990549 @default.
• W2034225161 cites W2141046053 @default.
• W2034225161 cites W2143180984 @default.
• W2034225161 cites W2167528781 @default.
• W2034225161 cites W2195147480 @default.
• W2034225161 cites W2414451354 @default.
• W2034225161 cites W4234101443 @default.
• W2034225161 cites W4251118184 @default.
• W2034225161 cites W4251892926 @default.
• W2034225161 cites W4382916220 @default.
• W2034225161 doi "https://doi.org/10.1016/j.ajog.2004.12.052" @default.
• W2034225161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15746665" @default.
• W2034225161 hasPublicationYear "2005" @default.
• W2034225161 type Work @default.
• W2034225161 sameAs 2034225161 @default.
• W2034225161 citedByCount "136" @default.
• W2034225161 countsByYear W20342251612012 @default.
• W2034225161 countsByYear W20342251612013 @default.
• W2034225161 countsByYear W20342251612014 @default.
• W2034225161 countsByYear W20342251612015 @default.
• W2034225161 countsByYear W20342251612016 @default.
• W2034225161 countsByYear W20342251612017 @default.
• W2034225161 countsByYear W20342251612018 @default.
• W2034225161 countsByYear W20342251612019 @default.
• W2034225161 countsByYear W20342251612020 @default.
• W2034225161 countsByYear W20342251612021 @default.
• W2034225161 countsByYear W20342251612022 @default.
• W2034225161 countsByYear W20342251612023 @default.
• W2034225161 crossrefType "journal-article" @default.
• W2034225161 hasAuthorship W2034225161A5005680652 @default.
• W2034225161 hasAuthorship W2034225161A5020083084 @default.
• W2034225161 hasAuthorship W2034225161A5047214799 @default.
• W2034225161 hasAuthorship W2034225161A5064904642 @default.
• W2034225161 hasAuthorship W2034225161A5066655749 @default.
• W2034225161 hasAuthorship W2034225161A5074359125 @default.
• W2034225161 hasAuthorship W2034225161A5079468194 @default.
• W2034225161 hasConcept C126322002 @default.
• W2034225161 hasConcept C134018914 @default.
• W2034225161 hasConcept C167734588 @default.
• W2034225161 hasConcept C2776871010 @default.
• W2034225161 hasConcept C2777025900 @default.
• W2034225161 hasConcept C2777218350 @default.
• W2034225161 hasConcept C2777583542 @default.
• W2034225161 hasConcept C2778376644 @default.
• W2034225161 hasConcept C2779184299 @default.
• W2034225161 hasConcept C2779234561 @default.
• W2034225161 hasConcept C54355233 @default.
• W2034225161 hasConcept C71924100 @default.
• W2034225161 hasConcept C77411442 @default.
• W2034225161 hasConcept C86803240 @default.
• W2034225161 hasConceptScore W2034225161C126322002 @default.
• W2034225161 hasConceptScore W2034225161C134018914 @default.
• W2034225161 hasConceptScore W2034225161C167734588 @default.
• W2034225161 hasConceptScore W2034225161C2776871010 @default.
• W2034225161 hasConceptScore W2034225161C2777025900 @default.
• W2034225161 hasConceptScore W2034225161C2777218350 @default.
• W2034225161 hasConceptScore W2034225161C2777583542 @default.
• W2034225161 hasConceptScore W2034225161C2778376644 @default.
• W2034225161 hasConceptScore W2034225161C2779184299 @default.
• W2034225161 hasConceptScore W2034225161C2779234561 @default.
• W2034225161 hasConceptScore W2034225161C54355233 @default.
• W2034225161 hasConceptScore W2034225161C71924100 @default.
• W2034225161 hasConceptScore W2034225161C77411442 @default.
• W2034225161 hasConceptScore W2034225161C86803240 @default.
• W2034225161 hasIssue "3" @default.
• W2034225161 hasLocation W20342251611 @default.
• W2034225161 hasLocation W20342251612 @default.
• W2034225161 hasOpenAccess W2034225161 @default.

• next